Urinary levels of pro-fibrotic transglutaminase 2 (TG2) may help predict progression of chronic kidney disease.
Michelle Da Silva Lodge, Nick Pullen, Miguel Pereira and 1 more
PLoS ONE · 2022
doi:10.1371/journal.pone.0262104 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
References72
- 64.
71 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.